# Cepheid Receives FDA Clearance for Xpert® Hemorrhagic Fever Panel Test

- Source: PR Newswire M&A
- Published: 2026-11-03T17:35:00+00:00
- Category: Business
- Original: https://www.prnewswire.com/news-releases/cepheid-receives-fda-clearance-for-xpert-hemorrhagic-fever-panel-test-302928141.html
- Canonical: https://groundlevelnews.com/story/cepheid-receives-fda-clearance-for-xpert-hemorrhagic-fever-panel-test-886cca/

New multiplex PCR test simultaneously detects Ebola, Marburg, Lassa and Crimean-Congo hemorrhagic fever viruses in approximately 61 minutes. SUNNYVALE, Calif., Nov. 3, 2026 /PRNewswire/ -- Cepheid, a Danaher operating company, today announced that the U.S. Food and Drug Administration...

_Ground Level News shows a short summary only; the full article and all rights belong to PR Newswire M&A._